Literature DB >> 24531208

Bad medicine: nalmefene in alcohol misuse.

Des Spence.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531208     DOI: 10.1136/bmj.g1531

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Comment on: "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".

Authors:  Alain Braillon
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

2.  Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Authors:  Alain Braillon; Francoise Taiebi; Amal Bernoussi
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

Review 3.  Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.

Authors:  Clément Palpacuer; Bruno Laviolle; Rémy Boussageon; Jean Michel Reymann; Eric Bellissant; Florian Naudet
Journal:  PLoS Med       Date:  2015-12-22       Impact factor: 11.069

4.  Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?

Authors:  Alain Braillon; Bernard Granger
Journal:  Subst Abuse Rehabil       Date:  2015-06-29

Review 5.  Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers.

Authors:  Niamh Fitzgerald; Kathryn Angus; Andrew Elders; Marisa de Andrade; Duncan Raistrick; Nick Heather; Jim McCambridge
Journal:  Addiction       Date:  2016-06-05       Impact factor: 6.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.